Dr Reddys Earnings Estimate

By analyzing Dr Reddys' earnings estimates, investors can diagnose different trends across Dr Reddys' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Dr Reddys Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options. Dr Reddys is projected to generate 17.1075 in earnings per share on the 31st of March 2026. Dr Reddys earnings estimates show analyst consensus about projected Dr Reddys Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Dr Reddys' historical volatility. Many public companies, such as Dr Reddys, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Dr Reddys' earnings estimates, investors can diagnose different trends across Dr Reddys' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about 199.9 B in 2025, whereas Pretax Profit Margin is likely to drop 0.12 in 2025. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.